Skip to main content
logo
Onco-Innovations Limited (NEO:ONCO)
Canada flag Canada · Delayed Price · Currency is CAD
0.5700
-0.0200 (-3.39%)
Aug 19, 2026, 3:55 PM EST

Onco-Innovations Financials Overview

Millions CAD. Fiscal year is May - Apr.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023
Period EndingApr '26 Apr '26 Apr '25 Apr '24 Apr '23
Revenue
0.110.110.07--
Revenue Growth
69.06%69.06%---
Gross Profit
0.110.110.07--
Operating Income
-7.42-7.42-3.03-0.39-0
Net Income
-10.78-10.78-7.56-0.39-0
Earnings Per Share
-0.19-0.19-0.19-0.11-
EPS Growth
-----

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023
Period EndingApr '26 Apr '26 Apr '25 Apr '24 Apr '23
Net Cash (Debt)
0.780.781.110.450.02
Net Cash Growth
-30.21%-30.21%148.24%2318.62%-
Net Cash Per Share
0.010.010.030.13-
Cash & Investments
0.780.781.110.450.02

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023
Period EndingApr '26 Apr '26 Apr '25 Apr '24 Apr '23
Operating Cash Flow
-5.27-5.27-3.87-0.01-0
Free Cash Flow
-5.27-5.27-3.87-0.01-0
Free Cash Flow Growth
-----

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023
Period EndingApr '26 Apr '26 Apr '25 Apr '24 Apr '23
Gross Margin
100.00%100.00%100.00%--
Operating Margin
-6725.91%-6725.91%-4646.69%--
Pretax Margin
-9763.39%-9763.39%-11580.58%--
Profit Margin
-9763.39%-9763.39%-11580.58%--

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023
Period EndingAug '26 Apr '26 Apr '25 Apr '24 Apr '23
PS Ratio
352.76701.551164.95--